Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Operating Margin 2010-2025 | SIGA

Current and historical operating margin for Siga Technologies (SIGA) over the last 10 years. The current operating profit margin for Siga Technologies as of June 30, 2025 is 45.73%.
  
Siga Technologies Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-06-30 $0.18B $0.10B 56.98%
2025-03-31 $0.12B $0.06B 47.50%
2024-12-31 $0.14B $0.07B 50.72%
2024-09-30 $0.17B $0.11B 60.69%
2024-06-30 $0.17B $0.10B 59.88%
2024-03-31 $0.16B $0.10B 62.18%
2023-12-31 $0.14B $0.08B 60.43%
2023-09-30 $0.03B $-0.01B -29.41%
2023-06-30 $0.10B $0.03B 35.05%
2023-03-31 $0.11B $0.04B 38.89%
2022-12-31 $0.11B $0.04B 38.74%
2022-09-30 $0.22B $0.14B 64.65%
2022-06-30 $0.15B $0.09B 62.84%
2022-03-31 $0.14B $0.09B 64.29%
2021-12-31 $0.13B $0.09B 66.42%
2021-09-30 $0.06B $0.02B 38.60%
2021-06-30 $0.10B $0.06B 60.42%
2021-03-31 $0.13B $0.09B 68.50%
2020-12-31 $0.13B $0.09B 68.00%
2020-09-30 $0.09B $0.06B 60.44%
2020-06-30 $0.06B $0.02B 41.82%
2020-03-31 $0.02B $-0.01B -42.11%
2019-12-31 $0.03B $0.00B -7.69%
2019-09-30 $0.02B $-0.01B -20.83%
2019-06-30 $0.49B $0.36B 74.54%
2019-03-31 $0.49B $0.36B 74.28%
2018-12-31 $0.48B $0.35B 74.06%
2018-09-30 $0.48B $0.36B 74.42%
2018-06-30 $0.01B $-0.02B -285.71%
2018-03-31 $0.01B $-0.02B -250.00%
2017-12-31 $0.01B $-0.02B -172.73%
2017-09-30 $0.02B $-0.02B -123.53%
2017-06-30 $0.02B $-0.02B -109.52%
2017-03-31 $0.02B $-0.03B -147.37%
2016-12-31 $0.02B $-0.03B -206.67%
2016-09-30 $0.01B $-0.04B -350.00%
2016-06-30 $0.01B $-0.04B -475.00%
2016-03-31 $0.01B $-0.03B -471.43%
2015-12-31 $0.01B $-0.03B -442.86%
2015-09-30 $0.00B $-0.03B -775.00%
2015-06-30 $0.00B $-0.21B -5225.00%
2015-03-31 $0.00B $-0.21B -5250.00%
2014-12-31 $0.00B $-0.21B -5275.00%
2014-09-30 $0.00B $-0.20B -5000.00%
2014-06-30 $0.01B $-0.02B -480.00%
2014-03-31 $0.01B $-0.03B -500.00%
2013-12-31 $0.01B $-0.03B -500.00%
2013-09-30 $0.01B $-0.02B -328.57%
2013-06-30 $0.01B $-0.02B -314.29%
2013-03-31 $0.01B $-0.02B -244.44%
2012-12-31 $0.01B $-0.02B -244.44%
2012-09-30 $0.01B $-0.03B -227.27%
2012-06-30 $0.01B $-0.03B -200.00%
2012-03-31 $0.01B $-0.03B -258.33%
2011-12-31 $0.01B $-0.03B -238.46%
2011-09-30 $0.01B $-0.03B -245.45%
2011-06-30 $0.01B $-0.02B -164.29%
2011-03-31 $0.02B $-0.02B -93.75%
2010-12-31 $0.02B $-0.01B -63.16%
2010-09-30 $0.02B $-0.01B -60.00%
2010-06-30 $0.02B $-0.01B -76.47%
2010-03-31 $0.02B $-0.01B -76.47%
2009-12-31 $0.01B $-0.01B -92.86%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.612B $0.139B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $65.985B 25.38
Zoetis (ZTS) United States $65.698B 23.83
Daiichi Sankyo, - (DSNKY) Japan $46.506B 23.83
Takeda Pharmaceutical (TAK) Japan $45.692B 9.32
BeOne Medicines - (ONC) Cayman Islands $32.693B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.460B 0.00
Summit Therapeutics (SMMT) United States $20.847B 0.00
Merck (MKKGY) Germany $15.858B 10.31
Shionogi (SGIOY) Japan $15.060B 15.09
United Therapeutics (UTHR) United States $13.506B 11.69
Neurocrine Biosciences (NBIX) United States $12.457B 37.16
IPSEN (IPSEY) France $10.420B 0.00
Orion OYJ (ORINY) Finland $10.275B 24.76
Madrigal Pharmaceuticals (MDGL) United States $7.600B 0.00
Corcept Therapeutics (CORT) United States $7.532B 63.26
Stevanato Group S.p.A (STVN) Italy $7.329B 43.21
Grifols, S.A (GRFS) Spain $7.322B 0.00
Ionis Pharmaceuticals (IONS) United States $6.543B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 17.90
Soleno Therapeutics (SLNO) United States $4.183B 0.00
Hypermarcas (HYPMY) Brazil $2.673B 20.09
Crinetics Pharmaceuticals (CRNX) United States $2.610B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.578B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.573B 12.25
Catalyst Pharmaceuticals (CPRX) United States $2.395B 8.05
Centessa Pharmaceuticals (CNTA) United Kingdom $2.296B 0.00
Ocular Therapeutix (OCUL) United States $2.140B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.753B 0.00
ARS Pharmaceuticals (SPRY) United States $1.733B 0.00
Dyne Therapeutics (DYN) United States $1.592B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.505B 22.41
Evotec AG (EVO) Germany $1.371B 0.00
Guardian Pharmacy Services (GRDN) United States $1.296B 0.00
Ardelyx (ARDX) United States $1.239B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.232B 0.00
Harrow (HROW) United States $1.218B 0.00
Collegium Pharmaceutical (COLL) United States $1.058B 5.67
Xeris Biopharma Holdings (XERS) United States $1.032B 0.00
Enliven Therapeutics (ELVN) United States $0.878B 0.00
Cronos Group (CRON) Canada $0.871B 0.00
Akebia Therapeutics (AKBA) United States $0.791B 0.00
ProKidney (PROK) United States $0.751B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.699B 0.00
Zevra Therapeutics (ZVRA) United States $0.663B 0.00
KalVista Pharmaceuticals (KALV) United States $0.632B 0.00
Elite Pharmaceuticals (ELTP) United States $0.605B 0.00
Relay Therapeutics (RLAY) United States $0.598B 0.00
Organogenesis (ORGO) United States $0.573B 0.00
Bioventus (BVS) United States $0.569B 13.86
Theravance Biopharma (TBPH) United States $0.561B 0.00
Tourmaline Bio (TRML) United States $0.548B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.546B 5.63
USANA Health Sciences (USNA) United States $0.530B 10.86
Xencor (XNCR) United States $0.522B 0.00
Oruka Therapeutics (ORKA) United States $0.512B 0.00
Savara (SVRA) United States $0.455B 0.00
Aquestive Therapeutics (AQST) United States $0.390B 0.00
Esperion Therapeutics (ESPR) United States $0.359B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.345B 0.00
Nanobiotix S.A (NBTX) France $0.339B 0.00
Aldeyra Therapeutics (ALDX) United States $0.310B 0.00
Larimar Therapeutics (LRMR) United States $0.303B 0.00
AleAnna (ANNA) United States $0.299B 0.00
Altimmune (ALT) United States $0.286B 0.00
Heron Therapeutics (HRTX) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 17.64
Nektar Therapeutics (NKTR) United States $0.270B 0.00
4D Molecular Therapeutics (FDMT) United States $0.268B 0.00
Galectin Therapeutics (GALT) United States $0.243B 0.00
OmniAb (OABI) United States $0.230B 0.00
MediWound (MDWD) Israel $0.203B 0.00
China SXT Pharmaceuticals (SXTC) China $0.183B 0.00
Lyell Immunopharma (LYEL) United States $0.175B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
MEI Pharma (MEIP) United States $0.165B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.142B 22.00
Avita Medical (RCEL) United States $0.142B 0.00
Liminatus Pharma (LIMN) United States $0.126B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Inhibikase Therapeutics (IKT) United States $0.115B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Avalo Therapeutics (AVTX) United States $0.090B 0.00
VAXART, INC (VXRT) United States $0.089B 0.00
Cardiol Therapeutics (CRDL) Canada $0.089B 0.00
ESSA Pharma (EPIX) Canada $0.084B 0.00
Champions Oncology (CSBR) United States $0.084B 19.09
Dominari Holdings (DOMH) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
BioNxt Solutions (BNXTF) Canada $0.081B 0.00
Vivani Medical (VANI) United States $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Surrozen (SRZN) United States $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Metagenomi (MGX) United States $0.072B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Inotiv (NOTV) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Wellgistics Health (WGRX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.051B 0.00
PolyPid (PYPD) Israel $0.051B 0.00
Telomir Pharmaceuticals (TELO) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.82
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Fractyl Health (GUTS) United States $0.048B 0.00
Plus Therapeutics (PSTV) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.043B 0.00
NRx Pharmaceuticals (NRXP) United States $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Scienture Holdings (SCNX) United States $0.036B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Cosmos Health (COSM) United States $0.030B 0.00
Mural Oncology (MURA) Ireland $0.029B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Incannex Healthcare (IXHL) Australia $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
BioVie (BIVI) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.39
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.19
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00